Finance Watch: Notable Neuroscience VC Deals Include Nura Bio’s $73m Launch

04 Aug 2020

• By Mandy Jackson, Ian Haydock, and Jung Won Shin

Private Company Edition: Several drug developers targeting neurological diseases raised venture capital recently. In addition to Nura Bio, Encoded Therapeutics revealed a $135m series D round. Also, Longwood closed a $170m fund and Flagship launched Omega Therapeutics with $85m.

Finance Watch: Notable Neuroscience VC Deals Include Nura Bio’s $73m Launch

More from Financing

More from Business